The synergistic anchoring of TOX3 with WDR5 at the promoter of ABCG2 causes the enrichment of histone H3K4 tri-methylation, thereby further promoting ABCG2 transcription and expression and subsequent cancer stem-like traits expansion and drug sensitivity deregulation. The gene discussed is TOX3; the disease is cancer.